Efficacy of FP-025: A novel matrix metalloproteinase-12 (MMP-12) inhibitor in murine allergic asthma
Language English Country Denmark Media print-electronic
Document type Letter, Research Support, Non-U.S. Gov't
PubMed
36094742
PubMed Central
PMC10087922
DOI
10.1111/all.15513
Knihovny.cz E-resources
- MeSH
- Asthma * drug therapy MeSH
- Humans MeSH
- Matrix Metalloproteinase 12 * MeSH
- Mice MeSH
- Lung MeSH
- Sulfur Compounds MeSH
- Tissue Inhibitor of Metalloproteinase-1 MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Mice MeSH
- Animals MeSH
- Publication type
- Letter MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- FP-025 MeSH Browser
- Matrix Metalloproteinase 12 * MeSH
- Sulfur Compounds MeSH
- Tissue Inhibitor of Metalloproteinase-1 MeSH
Department of Microbiology Immunology and Transplantation KU Leuven Leuven Belgium
Department of Pulmonary Medicine Amsterdam University Medical Center Amsterdam The Netherlands
See more in PubMed
Abd‐Elaziz K, Jesenak M, Vasakova M, Diamant Z. Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases. Curr Opin Pulm Med. 2021;27(1):54‐60. PubMed
Johnson JR, Wiley RE, Fattouh R, et al. Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med. 2004;169(3):378‐385. PubMed
Ravanetti L, Dijkhuis A, Dekker T, et al. IL‐33 drives influenza‐induced asthma exacerbations by halting innate and adaptive antiviral immunity. J Allergy Clin Immunol. 2019;143(4):1355‐1370 e1316. PubMed
Ravanetti L, Dijkhuis A, Sabogal Pineros YS, et al. An early innate response underlies severe influenza‐induced exacerbations of asthma in a novel steroid‐insensitive and anti‐IL‐5‐responsive mouse model. Allergy. 2017;72(5):737‐753. PubMed
Marchant DJ, Bellac CL, Moraes TJ, et al. A new transcriptional role for matrix metalloproteinase‐12 in antiviral immunity. Nat Med. 2014;20(5):493‐502. PubMed
Abd‐Elaziz K, Voors‐Pette C, Wang KL, et al. First‐in‐man safety, tolerability, and pharmacokinetics of a novel and highly selective inhibitor of matrix Metalloproteinase‐12, FP‐025: results from two randomized studies in healthy subjects. Clin Drug Investig. 2021;41(1):65‐76. PubMed
